Companies that reported less-than-expected earnings included ONGC, Infosys, Coal India, Maruti Suzuki, Bajaj Finserv, Tata Steel, UPL, Dr Reddy’s Labs and Cipla, among others.

Tata Motors, Bharti Airtel, HDFC Life: Stocks that saw upgrades in FY24 earnings estimates; should you buy these shares?

On Day 1 of ET Boardroom Dialogues, presented in partnership with Diageo India, GV Prasad, Co-chairman and Managing Director of Dr Reddy's Labs, speaks on the importance of building sustainable business practices that drive long-term growth and profitability. In a fireside chat with Miloni Bhatt, Editor - Digital Broadcast, EconomicTimes.com, GV Prasad also shares insights from Dr Reddy's Labs’ sustainability efforts and explores the opportunities and challenges of fostering a sustainable future through collective corporate action. 

To know more about the ET Boardroom Dialogues 2023, visit https://economictimes.indiatimes.com/spotlight/et_sustainability.cms

ET Boardroom Dialogues | GV Prasad of Dr Reddy's Labs on need for sustainable business practices

Motilal Oswal recommended Neutral rating on Dr Reddy’s Labs with a target price of Rs 4500 in its research report dated May 11, 2023.

Neutral Dr Reddy’s Labs; target of Rs 4500: Motilal Oswal

The S&P BSE Sensex and Nifty50 in India closed flat with a negative bias. Stocks in capital goods, healthcare, metals, and energy sectors experienced selling pressure, while consumer durables, FMCG, power, and utilities saw some buying. Ratnamani Metals rose over 6%, Dr Reddy’s Laboratories fell nea…

Big Movers on D-St: What should investors do with Ratnamani Metal, DR Reddy’s Laboratories and FSL?

While pharma major has maintained its margin guidance, expensive valuations limit upside

Dr Reddy’s Laboratories QoQ showing catches a cold on weak US sales

Dr Reddy’s Labs share price: Motilal Oswal Securities said while Dr Reddy’s Labs delivered 39 per cent YoY earnings growth in FY23, it expect moderation in the earnings CAGR to a mere 3.6 per cent over FY23-25.

Dr Reddy’s Labs shares at Rs 4,200? Stock sees price target cuts as gRevlimid sales wane

RVNL shares climbed 4.97% to Rs 127.90. This counter saw 2,29,40,445 shares changing hands, amounting to Rs 287 crore. IRFC shares jumped 3.65% to Rs 34.05, IRCON International advanced 7%.

RVNL, IRCON International, YES Bank, Zomato shares rally amid high volumes; L&T, Dr Reddy’s Labs log high turnovers

Dr Reddy’s Laboratories share price plunged nearly 7% on Thursday after the pharma major posted a lower-than-expected EBITDA, net profit and higher OPEX.

Dr Reddy’s Labs share price outlook: Weak Revlimid sales to hurt as pharma grows; Check brokerage calls, target | The Financial Express

Dr Reddy’s Laboratories Ltd (NYSE:NYSE:RDY) Q4 2023 Earnings Conference Call May 10, 2023 10:00 AM ETCompany ParticipantsRicha Periwal - IRGunupati Prasad - Co-ChairmanParag Agarwal -...

Dr Reddy’s Laboratories Ltd (RDY) Q4 2023 Earnings Call Transcript

Dr Reddy’s Laboratories reported an 890% YoY surge in March quarter profit at Rs 960.1 crore but shares tumbled nearly 7% to Rs 4,545 in Thursday’s trade. While its revenue from operations increased by 15.28% YoY to Rs 5,843 crore, total expenses were down 4% at Rs 5,132.2 crore. US revenues fell 17…

Dr Reddy’s tumbles 7% post Q4 results! Here’s what brokerages recommend

In Q4, the company’s North America’s revenue declined 17 per cent QoQ to Rs 2,530 crore, due to fluctuations in demand for new launches.

Dr Reddy’s Labs sinks 7% on disappointing Q4 operating performance

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.

Dr Reddy's Laboratories Ltd